Research Institute of General Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, Jiangsu, China.
International Genome Center, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.
Mol Cancer. 2022 Jun 22;21(1):133. doi: 10.1186/s12943-022-01596-8.
Undifferentiated carcinoma with osteoclast-like giant cells (OGCs) of pancreas (UCOGCP) is a rare subtype of pancreatic ductal adenocarcinoma (PDAC), which had poorly described histopathological and clinical features.
In this study, single-cell RNA sequencing (scRNA-seq) was used to profile the distinct tumor microenvironment of UCOGCP using samples obtained from one UCOGCP patient and three PDAC patients. Bioinformatic analysis was carried out and immunohistochemical (IHC) staining was used to support the findings of bioinformatic analysis. After quality control of the raw data, a total of 18,376 cells were obtained from these four samples for subsequent analysis. These cells were divided into ten main cell types following the Seurat analysis pipeline. Among them, the UCOGCP sample displayed distinct distribution patterns from the rest samples in the epithelial cell, myeloid cell, fibroblast, and endothelial cell clusters. Further analysis supported that the OGCs were generated from stem-cell-like mesenchymal epithelial cells (SMECs).
Functional analysis showed that the OGCs cluster was enriched in antigen presentation, immune response, and stem cell differentiation. Gene markers such as LOX, SPERINE1, CD44, and TGFBI were highly expressed in this SMECs cluster which signified poor prognosis. Interestingly, in myeloid cell, fibroblasts, and endothelial cell clusters, UCOGCP contained higher percentage of these cells and unique subclusters, compared with the rest of PDAC samples.
Analysis of cell communication depicted that CD74 plays important roles in the formation of the microenvironment of UCOGCP. Our findings illustrated the genesis and function of OGCs, and the tumor microenvironment (TME) of UCOGCP, providing insights for prognosis and treatment strategy for this rare type of pancreatic cancer.
胰腺未分化癌伴破骨样巨细胞(UCOGCP)是胰腺导管腺癌(PDAC)的一种罕见亚型,其组织病理学和临床特征描述较差。
本研究采用单细胞 RNA 测序(scRNA-seq)技术,对来自 1 例 UCOGCP 患者和 3 例 PDAC 患者的样本进行 UCOGCP 独特的肿瘤微环境进行分析。进行生物信息学分析,并进行免疫组织化学(IHC)染色以支持生物信息学分析的结果。对原始数据进行质量控制后,从这四个样本中总共获得了 18376 个细胞进行后续分析。这些细胞通过 Seurat 分析流程分为十个主要细胞类型。其中,UCOGCP 样本在上皮细胞、髓样细胞、成纤维细胞和内皮细胞簇中的分布模式与其他样本明显不同。进一步的分析支持这些破骨样巨细胞来源于干细胞样间充质上皮细胞(SMECs)。
功能分析表明,破骨样巨细胞簇富含抗原呈递、免疫反应和干细胞分化。LOX、SPERINE1、CD44 和 TGFBI 等基因标志物在这个 SMECs 簇中高度表达,提示预后不良。有趣的是,在髓样细胞、成纤维细胞和内皮细胞簇中,与其余 PDAC 样本相比,UCOGCP 中这些细胞的比例更高,并且存在独特的亚群。
细胞通讯分析表明,CD74 在 UCOGCP 微环境的形成中发挥重要作用。我们的研究结果说明了破骨样巨细胞的发生和功能以及 UCOGCP 的肿瘤微环境(TME),为这种罕见类型的胰腺癌的预后和治疗策略提供了新的见解。